false

/content/advancedmaterials/us/en/search-results.html

Solstice® Propellant, HFO-1234ze(E) for OTC Topical Analgesics

Redefine what OTC pain relief can feel like with Solstice propellant technology.

The Opportunity

Consumers expect more from every application

With sports injuries on the rise, the market for over-the-counter (OTC) topical analgesics is growing (Ref. 1 and 2). Solstice Propellant gives brands and formulators the propellant technology and technical support to create differentiated pain relief products.

Consumer applying a topical pain relief product
Key Features

Built to create a more differentiated consumer experience

01

Dual-Sensory Experience

Solstice Propellant provides immediate physical skin cooling from the moment of application, before the API’s analgesic effect. When formulated with an API, this creates a premium two-stage sensory experience: an immediate cooling sensation followed by the API’s analgesic effect.

02

Premium Sensory Formats

Achieve precise mist sprays, richer foams and novel textures, with a smoother, pleasant feel on skin than common hydrocarbon propellants. (Ref. 3).

03

Demonstrated Active Pharmaceutical Ingredient Stability

Many common OTC actives are highly soluble and stable in formulation with Solstice Propellant and ethanol. (Ref. 8)

04

End-to-End Technical Support

With over five decades of combined propellant innovation, Solstice works directly with brands and formulators from proof-of-concept through to commercialization.

05

Future-Ready

With a low 100-year global warming potential (GWP) of 1.37, substantially lower than legacy HFC propellants such as HFC-134a (GWP ~1,300) (Ref. 4), and classification by the U.S. EPA as volatile organic compound (VOC)-exempt (Ref. 5), Solstice Propellant is designed to help formulators address specific regulatory drivers such as the HFC phasedown and evolving VOC requirements. It is also classified as non-flammable under EC Test Method A11 and the US DOT standard (ASTM E681) (Ref. 6), offering added confidence for formulators and manufacturers alike.

Watch the Video

Solstice Propellant for OTC topical analgesics video

Novel Cooling Sensation

A sensory experience hydrocarbons may not be able to replicate

HFO propellant technology is already proven in applications for rapid skin cooling at the point of care. (Ref. 7) Solstice Propellant brings the possibility of a unique sensory experience to OTC topical analgesics market. (Ref. 3)

Dual-Sensory Experience

Today, most commonly sold OTC pain sprays reduce pain by targeting the nerves using active pharmaceutical ingredients, but the consumer may experience discomfort from a solution that is either too warm or too cold on impact.

Solstice Propellant evaporates when sprayed on the skin, providing immediate physical cooling within a comfortable range without freezing the skin, before the API’s analgesic effect. (Ref. 3)

This is dual-sensory experience. When formulated with an API, Solstice Propellant, creates a premium two-stage sensory experience: an immediate cooling sensation followed by the API’s analgesic effect. For consumers, this provides an immediate, perceptible cooling sensation on application. (Ref. 3)

Cooling performance is fully tunable and can be optimized through HFO propellant blending, formulation design, hardware selection, and other parameters which helps brands create a differentiated product experience.

Learn more in our dual-sensory experience blog
Topical spray application demonstrating a cooling effect
Formulation Capabilities

The tools to create truly differentiated products

Solstice Propellant helps brands create truly differentiated product experiences.

Laboratory formulation and stability testing

Soluble and Stable

A three-month study confirmed that seven common OTC APIs remain stable in formulation with Solstice Propellant and ethanol, giving formulators a starting point across some of the most widely used OTC analgesic actives. (Ref. 3 and 8)

  • Benzocaine
  • Benzethonium Chloride
  • Menthol
  • Chlorhexidine Digluconate
  • Lidocaine
  • Camphor
  • Methyl Salicylate
Premium foam and spray product formats

Premium Formats

Beyond enhanced cooling performance, Solstice Propellant gives formulators greater flexibility to develop premium sensory formats.

  • Compared with hydrocarbon propellants, it enables richer, creamier foams with enhanced spreadability (Ref. 3)
  • Supports a range of spray profiles, from fine mist sprays to larger stream-like patterns, to meet different product and application requirements.
Aerosol spray system delivering consistent pressure

Consistent Performance

Solstice Propellant also offers advantages over bag-on-valve (BOV) systems used for topical pain relief sprays. As a liquefied gas, Solstice Propellant provides immediate physical skin cooling while maintaining consistent spray pressure and performance throughout the life of the product, helping deliver a more consistent premium sensory experience.

The Right Partner

End-to-end technical support

Solstice research and development scientists bring over five decades of experience in combined advanced propellant innovation to bear to help innovators optimize their OTC formulations.

01

Proof-of-concept prototype development and custom starting formulations

02

API compatibility and stability testing across key OTC actives

03

In-house flammability testing

04

Spray particle analysis and hardware compatibility assessments

05

Physical property assessments and formulation troubleshooting

06

Regulatory considerations

FAQ

Solstice Propellant FAQs

What is dual-sensory experience in OTC topical analgesics?

Solstice Propellant provides immediate physical skin cooling from the moment of application, before the API’s analgesic effect. When formulated with an API, this creates a premium two-stage sensory experience: an immediate cooling sensation followed by the API’s analgesic effect. For consumers, this provides an immediate, perceptible cooling sensation on application, while helping brands create a differentiated product experience.

How does Solstice Propellant compare to hydrocarbon propellants?

Solstice Propellant enables premium sensory formats including richer foams and precise spray patterns, provides a gentler feel on skin (Ref. 3), and is VOC-exempt (Ref. 5) and non-flammable (Ref. 6).

Are common OTC APIs stable with Solstice Propellant?

Yes. A three-month stability study demonstrated that common OTC actives including menthol, lidocaine, benzocaine, and camphor are highly soluble and stable in formulation with Solstice Propellant and ethanol. (Ref. 3 and 8)

How compliant is Solstice Propellant with regulations for the topical OTC market?

Solstice Propellant is well positioned for an evolving regulatory landscape. The phasedown of HFCs under the AIM Act and New York's phase-out of HFC-152a (Ref. 9) are HFC-specific measures that operate separately from state-level restrictions on VOCs, which vary by jurisdiction and product category. Together, these pressures are prompting formulators to evaluate alternative propellant technologies. Solstice Propellant offers a compelling profile in this context: it has a low 100-year GWP (Ref. 4), is classified as non-flammable under both EC Test Method A11 and the U.S. DOT standard (ASTM E681) (Ref. 6) and is recognized by the U.S. EPA as VOC-exempt (Ref. 5).

Does Solstice work with any CDMO or contract manufacturer?

Yes. Solstice is CDMO-agnostic. The technical support, prototype development, and formulation guidance that Solstice provides is entirely independent of manufacturing partners. Solstice works with brand owners directly and hands off to whichever CDMO or filler the brand chooses to work with. Since it is non-flammable (Ref. 6), even CDMOs that do not have flammable handling capabilities maybe able to work with it..

Formulation Guide

Bring professional-grade cooling to your next formulation

Download the formulator's guide to see how Solstice® Propellant can help you bring professional-grade cooling technology to the OTC pain relief market.

References & Disclaimers

Finished-product safety, flammability, labeling, and compliance with applicable OTC monograph requirements are the responsibility of the brand owner and manufacturer. The properties of the neat propellant do not establish compliance or safety of any finished formulation.

  1. Mordor Intelligence: OTC Analgesics Market — Growth, Trends, and Forecasts (2026-2031).
  2. Sports Injuries in 65 and Older Significantly Increased Since 2012, Projected to Grow by 123% by 2040 - AAOS 2024 Annual Meeting Press Kit.
  3. Supporting data from Solstice internal attributes, foam property and feel, temperature and chemical compatibility testing. For more information, contact us at https://www.solstice.com/us/en/contact-us/sales-inquiry/solvents-propellants.
  4. https://www.ipcc.ch/report/ar6/wg1/chapter/chapter-7/#7.6

    (Section 7.6.1.1) Smith, C., Z.R.J. Nicholls, K. Armour, W. Collins, P. Forster, M. Meinshausen, M.D. Palmer, and M. Watanabe, 2021: The Earth’s Energy Budget, Climate Feedbacks, and Climate Sensitivity Supplementary Material. In Climate Change 2021: The Physical Science Basis. Contribution of Working Group I to the Sixth Assessment Report of the Intergovernmental Panel on Climate Change [Masson-Delmotte, V., P. Zhai, A. Pirani, S.L. Connors, C. Péan, S. Berger, N. Caud, Y. Chen, L. Goldfarb, M.I. Gomis, M. Huang, K. Leitzell, E. Lonnoy, J.B.R. Matthews, T.K. Maycock, T. Waterfield, O. Yelekçi, R. Yu, and B. Zhou (eds.)]. Available from https://www.ipcc.ch/

    The GWP classification applies to the neat propellant under the referenced test conditions only. The GWP of any finished formulation—must be independently assessed and/or tested

  5. The U.S. EPA currently classifies HFO-1234ze(E) as VOC-exempt. The VOC exemption classification applies to the neat propellant under the referenced test conditions only. The VOC exemption of any finished formulation—must be independently assessed and/or tested.
  6. Solstice Propellant is classified as non-flammable per EU Test Method A11 and ASTM Standard E681. This classification applies only to the neat propellant and only under the referenced test conditions. The flammability of any finished formulation, particularly one containing flammable excipients such as ethanol, must be independently assessed and tested for actual formulations, equipment and manufacturing processes.
  7. There is a commercially available topical anesthetic spray containing Solstice Propellant.
  8. Ethanol is a flammable excipient, this stability result does not establish that the finished formulation is non-flammable; finished-product flammability must be independently assessed and tested.
  9. New York Department of Environmental Conservation: Part 494 Fact Sheet.